These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 33866194)
1. The spectrum of tumors harboring BAP1 gene alterations. Laitman Y; Newberg J; Molho RB; Jin DX; Friedman E Cancer Genet; 2021 Aug; 256-257():31-35. PubMed ID: 33866194 [TBL] [Abstract][Full Text] [Related]
2. Somatic Mutation of BAP1 Can Lead to Expression Loss in Non-Small Cell Lung Carcinoma: Next Generation Sequencing and IHC Analysis in A Large Single Institute Cohort. Sun T; Wang X; Wang M; Minerowicz C; Sanchez H; Laskin W; Cohen P; Zhong M Int J Surg Pathol; 2022 Aug; 30(5):512-519. PubMed ID: 34970936 [No Abstract] [Full Text] [Related]
4. BAP1 Syndrome - Predisposition to Malignant Mesothelioma, Skin and Uveal Melanoma, Renal and Other Cancers. Foretová L; Navrátilová M; Svoboda M; Házová J; Vašíčková P; Sťahlová EH; Fabian P; Schneiderová M; Macháčková E Klin Onkol; 2019; 32(Supplementum2):118-122. PubMed ID: 31409087 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide. Walpole S; Pritchard AL; Cebulla CM; Pilarski R; Stautberg M; Davidorf FH; de la Fouchardière A; Cabaret O; Golmard L; Stoppa-Lyonnet D; Garfield E; Njauw CN; Cheung M; Turunen JA; Repo P; Järvinen RS; van Doorn R; Jager MJ; Luyten GPM; Marinkovic M; Chau C; Potrony M; Höiom V; Helgadottir H; Pastorino L; Bruno W; Andreotti V; Dalmasso B; Ciccarese G; Queirolo P; Mastracci L; Wadt K; Kiilgaard JF; Speicher MR; van Poppelen N; Kilic E; Al-Jamal RT; Dianzani I; Betti M; Bergmann C; Santagata S; Dahiya S; Taibjee S; Burke J; Poplawski N; O'Shea SJ; Newton-Bishop J; Adlard J; Adams DJ; Lane AM; Kim I; Klebe S; Racher H; Harbour JW; Nickerson ML; Murali R; Palmer JM; Howlie M; Symmons J; Hamilton H; Warrier S; Glasson W; Johansson P; Robles-Espinoza CD; Ossio R; de Klein A; Puig S; Ghiorzo P; Nielsen M; Kivelä TT; Tsao H; Testa JR; Gerami P; Stern MH; Paillerets BB; Abdel-Rahman MH; Hayward NK J Natl Cancer Inst; 2018 Dec; 110(12):1328-1341. PubMed ID: 30517737 [TBL] [Abstract][Full Text] [Related]
6. Somatic alteration and depleted nuclear expression of BAP1 in human esophageal squamous cell carcinoma. Mori T; Sumii M; Fujishima F; Ueno K; Emi M; Nagasaki M; Ishioka C; Chiba N Cancer Sci; 2015 Sep; 106(9):1118-29. PubMed ID: 26081045 [TBL] [Abstract][Full Text] [Related]
7. BAP1: Not just a BRCA1-associated protein. Louie BH; Kurzrock R Cancer Treat Rev; 2020 Nov; 90():102091. PubMed ID: 32877777 [TBL] [Abstract][Full Text] [Related]
8. Tissue-specific significance of BAP1 gene mutation in prognostic prediction and molecular taxonomy among different types of cancer. Wang XY; Wang Z; Huang JB; Ren XD; Ye D; Zhu WW; Qin LX Tumour Biol; 2017 Jun; 39(6):1010428317699111. PubMed ID: 28618948 [TBL] [Abstract][Full Text] [Related]
9. Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 Mutations. Zauderer MG; Jayakumaran G; DuBoff M; Zhang L; Francis JH; Abramson DH; Cercek A; Nash GM; Shoushtari A; Chapman P; D'Angelo S; Arnold AG; Siegel B; Fleischut MH; Ni A; Rimner A; Rusch VW; Adusumilli PS; Travis W; Sauter JL; Zehir A; Mandelker D; Ladanyi M; Robson M J Thorac Oncol; 2019 Nov; 14(11):1989-1994. PubMed ID: 31323388 [TBL] [Abstract][Full Text] [Related]
10. Germline BAP1 mutations predispose to malignant mesothelioma. Testa JR; Cheung M; Pei J; Below JE; Tan Y; Sementino E; Cox NJ; Dogan AU; Pass HI; Trusa S; Hesdorffer M; Nasu M; Powers A; Rivera Z; Comertpay S; Tanji M; Gaudino G; Yang H; Carbone M Nat Genet; 2011 Aug; 43(10):1022-5. PubMed ID: 21874000 [TBL] [Abstract][Full Text] [Related]
11. Sensitivity of Mesothelioma Cells to PARP Inhibitors Is Not Dependent on BAP1 but Is Enhanced by Temozolomide in Cells With High-Schlafen 11 and Low-O6-methylguanine-DNA Methyltransferase Expression. Rathkey D; Khanal M; Murai J; Zhang J; Sengupta M; Jiang Q; Morrow B; Evans CN; Chari R; Fetsch P; Chung HJ; Xi L; Roth M; Filie A; Raffeld M; Thomas A; Pommier Y; Hassan R J Thorac Oncol; 2020 May; 15(5):843-859. PubMed ID: 32004714 [TBL] [Abstract][Full Text] [Related]
12. Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes. Betti M; Aspesi A; Ferrante D; Sculco M; Righi L; Mirabelli D; Napoli F; Rondón-Lagos M; Casalone E; Vignolo Lutati F; Ogliara P; Bironzo P; Gironi CL; Savoia P; Maffè A; Ungari S; Grosso F; Libener R; Boldorini R; Valiante M; Pasini B; Matullo G; Scagliotti G; Magnani C; Dianzani I Genes Chromosomes Cancer; 2018 Nov; 57(11):573-583. PubMed ID: 30338612 [TBL] [Abstract][Full Text] [Related]
13. Intrahepatic cholangiocarcinoma development in a patient with a novel BAP1 germline mutation and low exposure to asbestos. Brandi G; Deserti M; Palloni A; Turchetti D; Zuntini R; Pedica F; Frega G; De Lorenzo S; Abbati F; Rizzo A; Di Marco M; Massari F; Tavolari S Cancer Genet; 2020 Oct; 248-249():57-62. PubMed ID: 33093002 [TBL] [Abstract][Full Text] [Related]
14. Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 Mutations. Kadariya Y; Cheung M; Xu J; Pei J; Sementino E; Menges CW; Cai KQ; Rauscher FJ; Klein-Szanto AJ; Testa JR Cancer Res; 2016 May; 76(9):2836-44. PubMed ID: 26896281 [TBL] [Abstract][Full Text] [Related]
15. Genomic profiling of the genes on chromosome 3p in sporadic clear cell renal cell carcinoma. Togo Y; Yoshikawa Y; Suzuki T; Nakano Y; Kanematsu A; Zozumi M; Nojima M; Hirota S; Yamamoto S; Hashimoto-Tamaoki T Int J Oncol; 2016 Apr; 48(4):1571-80. PubMed ID: 26891804 [TBL] [Abstract][Full Text] [Related]
16. Roles and mechanisms of BAP1 deubiquitinase in tumor suppression. Masclef L; Ahmed O; Estavoyer B; Larrivée B; Labrecque N; Nijnik A; Affar EB Cell Death Differ; 2021 Feb; 28(2):606-625. PubMed ID: 33462414 [TBL] [Abstract][Full Text] [Related]
17. Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of Cancer. Ohar JA; Cheung M; Talarchek J; Howard SE; Howard TD; Hesdorffer M; Peng H; Rauscher FJ; Testa JR Cancer Res; 2016 Jan; 76(2):206-15. PubMed ID: 26719535 [TBL] [Abstract][Full Text] [Related]
18. Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations. Gupta MP; Lane AM; DeAngelis MM; Mayne K; Crabtree M; Gragoudas ES; Kim IK JAMA Ophthalmol; 2015 Aug; 133(8):881-7. PubMed ID: 25974357 [TBL] [Abstract][Full Text] [Related]
19. Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature. Haugh AM; Njauw CN; Bubley JA; Verzì AE; Zhang B; Kudalkar E; VandenBoom T; Walton K; Swick BL; Kumar R; Rana HQ; Cochrane S; McCormick SR; Shea CR; Tsao H; Gerami P JAMA Dermatol; 2017 Oct; 153(10):999-1006. PubMed ID: 28793149 [TBL] [Abstract][Full Text] [Related]
20. [Malignant mesothelioma and constitutional BAP1 gene mutations]. Neviere Z; Berthet P; Polycarpe F; Dubos-Arvis C; Dô P; Gervais R Rev Mal Respir; 2019 Feb; 36(2):241-248. PubMed ID: 30686559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]